What topics does this cannabis study cover?

This study covers research on: Addiction, Mental Health.

Where was this research published?

Published in Journal of general internal medicine on September 28, 2026.

Addiction Mental Health

Colorado cohort links CUD diagnosis with higher mortality, but cannot…

Cannabis Use Disorder and Mortality Risk: A Matched Cohort Study from a Colorado Health System.

Journal of general internal medicine • September 28, 2026 • Highly Relevant

🤖

AI Summary

This matched observational cohort study asked whether a diagnosis of cannabis use disorder (CUD) was associated with mortality among people aged 12 or older in a Colorado health system. It compared 16,693 people with CUD with 83,447 matched people without CUD, with a median follow-up of 7.7 years. The primary outcomes were death from any cause, injury-related causes, and illness-related causes.

After adjustment, CUD diagnosis was associated with higher risks of all-cause mortality (HR 1.52), injury-related mortality (HR 1.91), and illness-related mortality (HR 1.40). Among specific causes, the study also found elevated risks associated with drug overdose, accidents, and cancer; it did not find statistically clear associations with self-harm, cardiovascular disease, or respiratory disease. These are associations, not proof that CUD caused the deaths. Because this is an abstract-based summary of an observational study, it cannot establish causation or explain how the findings apply beyond this health-system population; the abstract does not report all potential limitations or details of adjustment.

💡 Key Findings

In this matched cohort, CUD diagnosis was associated with higher all-cause mortality after adjustment (HR 1.52; 95% CI, 1.30–1.77).

High

90%

CUD diagnosis was associated with higher adjusted injury-related mortality (HR 1.91; 95% CI, 1.37–2.67) and illness-related mortality (HR 1.40; 95% CI, 1.17–1.67).

High

90%

The study reported elevated mortality associations for drug overdose, accidents, and cancer, but not statistically clear associations for self-harm, cardiovascular disease, or respiratory disease.

High

85%

Because the study is observational, it shows an association and cannot establish that CUD caused the increased mortality risk.

High

95%

📄 Original Abstract

BACKGROUND: Cannabis use disorder (CUD) is an underrecognized consequence of cannabis use, and evidence on mortality risk and leading causes of death among individuals with CUD remains limited. OBJECTIVE: To characterize all-cause and cause-specific mortality following CUD diagnosis and compare mortality risk between individuals with and without CUD. DESIGN, SETTING, AND PARTICIPANTS: This matched cohort study consisted of 100,140 individuals aged 12 years or older from a Colorado health system between 2006 and 2024, including 16,693 with a CUD diagnosis and 83,447 individuals without CUD, with follow-up through June 2024. MAIN MEASURES: Primary outcomes were all-cause mortality, injury-related mortality, and illness-related mortality identified from state vital records. Secondary outcomes included deaths from drug overdose, self-harm, accidents, cancer, cardiovascular diseases, and respiratory diseases. Cox proportional hazards regressions estimated adjusted hazard ratios (HRs) and 95% CIs. KEY RESULTS: Over a median follow-up of 7.7 years, 1,197 (7.2%) individuals with CUD died. Compared to matched individuals, those with CUD had higher crude rates of all-cause mortality (899.5 vs. 374.6 per 100,000 person-years), injury-related mortality (295.3 vs 62.5 per 100,000 person-years), and illness-related mortality (604.2 vs. 312.1 per 100,000 person-years). In adjusted analyses, CUD was associated with increased risk of all-cause mortality (HR 1.52; 95% CI, 1.30-1.77), injury-related mortality (HR 1.91; 95% CI, 1.37-2.67), and illness-related mortality (HR 1.40; 95% CI 1.17-1.67). Among leading causes, CUD was associated with elevated mortality risk from drug overdose (HR 2.59; 95% CI, 1.30-5.19), accidents (HR 1.96; 95% CI, 1.01-3.80), and cancer (HR 1.71; 95% CI, 1.20-2.46), but not self-harm (HR 1.18; 95% CI 0.62-2.24), cardiovascular diseases (HR 1.25; 95% CI 0.87-1.81), or respiratory diseases (HR 1.29; 95% CI, 0.73-2.25). CONCLUSIONS: CUD may serve as a marker of increased all-cause, injury-related, and illness-related mortality risk. Comprehensive prevention strategies are needed to address elevated mortality risk in individuals with CUD.

Paper Type

📄 Research

Publication

Journal: Journal of general internal medicine
Published: September 28, 2026
PMID: 42806222
DOI: 10.1007/s11606-026-10845-1

Authors (5)

Anh P Nguyen Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA. Anh.P.Nguyen@KP.org.
Komal J Narwaney Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Jason A Lyons Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Morgan A Ford Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Claudia A Steiner Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.